Arielle Butts, Ph.D.
Affiliations: | 2013 | School of Arts and Sciences | University of Rochester, Rochester, NY |
Area:
Molecular Chemistry, Microbiology Biology, Organic ChemistryGoogle:
"Arielle Butts"Parents
Sign in to add mentorDamian Krysan | grad student | 2013 | Rochester | |
(Repurposing Triphenylethylene Estrogen Receptor Antagonists as Anticryptococcal Agents.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Njikan S, Ahmed S, Manning A, et al. (2022) Chemical Exploration of a Highly Selective Scaffold with Activity against Intracellular . Microbiology Spectrum. e0116122 |
Butts A, Reitler P, Nishimoto AT, et al. (2019) A systematic screen reveals a diverse collection of medications induce antifungal resistance in species. Antimicrobial Agents and Chemotherapy |
Luna-Tapia A, Butts A, Palmer GE. (2018) Loss of C-5 sterol desaturase activity in - azole resistance or merely trailing growth? Antimicrobial Agents and Chemotherapy |
Butts A, Reitler P, Ge W, et al. (2018) Commonly used oncology drugs decrease antifungal effectiveness against and species. Antimicrobial Agents and Chemotherapy |
Butts A, DeJarnette C, Peters TL, et al. (2017) Target Abundance-Based Fitness Screening (TAFiS) Facilitates Rapid Identification of Target-Specific and Physiologically Active Chemical Probes. Msphere. 2 |
Butts A, Palmer GE, Rogers PD. (2016) Antifungal adjuvants: preserving and extending the antifungal arsenal. Virulence. 0 |
Butts A, Martin JA, DiDone L, et al. (2015) Structure-activity relationships for the antifungal activity of selective estrogen receptor antagonists related to tamoxifen. Plos One. 10: e0125927 |
Brown JC, Nelson J, VanderSluis B, et al. (2014) Unraveling the biology of a fungal meningitis pathogen using chemical genetics. Cell. 159: 1168-87 |
Butts A, Koselny K, Chabrier-Roselló Y, et al. (2014) Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo. Mbio. 5: e00765-13 |
Butts A, DiDone L, Koselny K, et al. (2013) A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis. Eukaryotic Cell. 12: 278-87 |